Clinical Trial

Evaluation of Esophagogastric Cancer Treatment With Nivolumab in Daily Clinical Practice

Name: Evaluation of Esophagogastric Cancer Treatment With Nivolumab in Daily Clinical Practice — clinical trial record (NCT07663786)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Active, Not Recruiting

View on ClinicalTrials.gov →

Summary

This study uses existing cancer registry and health record data to understand how nivolumab is used in routine care in the Netherlands for adults with advanced cancers of the esophagus, gastroesophageal junction, or stomach.

Trial Details

NCT Number	NCT07663786
Lead Sponsor	Bristol-Myers Squibb
Conditions	Esophageal Adenocarcinoma, Gastro-esophageal Junction Adenocarcinoma, Gastric Adenocarcinoma
Enrollment	726 participants
Start Date	2025-10-09
Primary Completion	2026-10-01 (estimated)
Study Completion	2027-02-01 (estimated)
Updated on ClinicalTrials.gov	2026-06-23